Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10037138HBVENSG00000185313.9protein_codingSCN10ANoNo6336Q9Y5Y9
TVIS20042252HPVENSG00000185313.9protein_codingSCN10ANoNo6336Q9Y5Y9
TVIS44012590HTLV-1ENSG00000185313.9protein_codingSCN10ANoNo6336Q9Y5Y9
TVIS44019094HTLV-1ENSG00000185313.9protein_codingSCN10ANoNo6336Q9Y5Y9
TVIS44025068HTLV-1ENSG00000185313.9protein_codingSCN10ANoNo6336Q9Y5Y9
TCGA Plot Options
Drug Information
GeneSCN10A
DrugBank IDDB00281
Drug NameLidocaine
Target IDBE0000177
UniProt IDQ9Y5Y9
Regulation Typeinhibitor
PubMed IDs17077153; 19088384; 20585544
CitationsEkberg J, Jayamanne A, Vaughan CW, Aslan S, Thomas L, Mould J, Drinkwater R, Baker MD, Abrahamsen B, Wood JN, Adams DJ, Christie MJ, Lewis RJ: muO-conotoxin MrVIB selectively blocks Nav1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficits. Proc Natl Acad Sci U S A. 2006 Nov 7;103(45):17030-5. Epub 2006 Oct 31.@@Muroi Y, Chanda B: Local anesthetics disrupt energetic coupling between the voltage-sensing segments of a sodium channel. J Gen Physiol. 2009 Jan;133(1):1-15. doi: 10.1085/jgp.200810103. Epub 2008 Dec 15.@@Karoly R, Lenkey N, Juhasz AO, Vizi ES, Mike A: Fast- or slow-inactivated state preference of Na+ channel inhibitors: a simulation and experimental study. PLoS Comput Biol. 2010 Jun 17;6(6):e1000818. doi: 10.1371/journal.pcbi.1000818.
GroupsApproved; Vet_approved
Direct Classificationm-Xylenes
SMILESCCN(CC)CC(=O)NC1=C(C)C=CC=C1C
PathwaysLidocaine (Antiarrhythmic) Action Pathway; Lidocaine (Local Anaesthetic) Metabolism Pathway; Lidocaine (Local Anaesthetic) Action Pathway
PharmGKBPA450226
ChEMBLCHEMBL79